
CSE: MDMA
PharmAla Biotech Positioned to Supply U.S. Expanded Access Pathway for MDMA Established by Presidential Executive Order

PharmAla Biotech Positioned to Supply U.S. Expanded Access Pathway for MDMA Established by Presidential Executive Order
Red Light Holland Highlights U.S. FDA-Authorized Study Supporting Multi-Session Psilocybin Therapy using Filament Health's Patented PEX010 Botanical Drug Candidate
Optimi Health Launches Ibogaine Initiative as U.S. Executive Order Signals Pathway for Psychedelic Drug Products
HYTN Introduces HARd Remediation to GMP Processing Services, Releases Product in Germany
iAnthus Expands Florida Footprint with new Dispensary Presence in Jupiter, FL
Trulieve to Open Medical Cannabis Dispensary in Tallahassee, Florida
PharmaCielo Announces Intention to Issue Interest Shares
LEEF Brands Announces Acquisition of HIMALAYA, a Leading California Concentrates Brand, to Expand Vertical Integration and Drive Margin Expansion
Decibel Reports Full-Year and Fourth Quarter 2025 Results: Revenue Grows 22% to $113 Million, Issues 2026 Guidance
Curaleaf Launches Share Repurchase Program
Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities
Tilray Brands Accelerates Next Phase of Global Growth and Market Leadership
Aurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company, Expanding EU GMP Capacity to Serve Growing High Margin International Markets
SEDAR Interim Financial Statements
Avant Brands Reports Q1 2026 Results Highlighted by 37% Growth in Recreational Revenue